期刊文献+

阿托伐他汀治疗60例高脂血症的疗效观察 被引量:4

下载PDF
导出
摘要 目的:探讨阿托伐他汀治疗高脂血症的疗效及安全性。方法:选择本院2005年1月~2010年1月住院治疗的60例高脂血症患者,给予阿托伐他汀治疗,观察比较不同治疗时间血脂指标的变化及疗效。结果:治疗4、12周后,总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、载脂蛋白a(Lpa)均较治疗前明显改善,经t检验及F检验显示,差异有统计学意义。结论:阿托伐他汀治疗高脂血症疗效好,可降低血脂及胆固醇,且不良反应少,值得临床广泛推广和应用。
作者 李桂芝
出处 《中国当代医药》 2010年第31期64-64,共1页 China Modern Medicine
  • 相关文献

参考文献6

二级参考文献21

  • 1王刚,孙备,姜洪池.高脂血症急性胰腺炎的研究进展[J].中国普通外科杂志,2005,14(11):857-859. 被引量:74
  • 2李昂,李非.近年急性胰腺炎发病的病因学分析[J].实用医学杂志,2006,22(8):918-919. 被引量:40
  • 3LaRosa JC,He J,Vupputuri HS,Effect of statin on risk of coronary disease:A meta-analysis of randomized rails[J].JAMA,1999,282:2340-2346.
  • 4Cleeman JI.Executive summary of the third report of the national cholesterol education program(NCEP)expert panel on erection,evaluation,and treatrnent of high blood cholesterol in adults (adult treatment panel Ⅲ)[J].JAMA,2001; 285:2486-2497.
  • 5Ridker PM,Rifai N,Pfeffer Ma,et al.For the Cholesterol and Recurrent Events(CARE) Investigations.Long-term effect of pravastatin on plasma concertration of C-reactive protein[J].Circulation,1999,100:230-235.
  • 6Navarro S,Cubiella J,Feu F,et al.Hypertriglyceriidemic acute pancreatitis is its clinical course different from lithiasic acute pancreatitisl[J].Med Clin(Bare),2004,123(15):567-570.
  • 7[3]Albere MA,Ridker PM.The role of C-reactive protein in cardiovascular disease risk.Curr Cardial Rep,1999,1:99~104
  • 8[4]Ridker PM,Rifai N,Clearfield M.Measurement of C-reactive protein for the target of seatin therapy in the primary provention of acute coronary events.N Engl J Med,2001,344:1959~1965
  • 9[5]Ridker PM,Rifai N,Pfeffer MA,et al.Inflammation,pravaseatin and the risk of coronary events after myocardial infarction in patients with average cholesterol levels.Circulation,1998,98:839~844
  • 10Searles GE,Ooi TC,Underrecognition of chylomicronemiaas a cause of acute pancreatitis[J] CMA J,1992,147:1806.

共引文献32

同被引文献36

  • 1雷蕾,张熙洋,崔立芹,王意忠,贾晓琳.阿托伐他汀和瑞舒伐他汀对2型糖尿病血脂和高敏C反应蛋白作用效果的比较[J].中华临床医师杂志(电子版),2012,6(19):6049-6051. 被引量:18
  • 2李焰生.他汀类药物与缺血性卒中的二级预防[J].中华内科杂志,2007,46(4):342-343. 被引量:6
  • 3张蔚.他汀类药物治疗高脂血症的临床应用[J].新医学,2007,38(5):330-331. 被引量:22
  • 4高润霖主编.心血管病治疗指南和建议第1版.北京:人民军医出版社,2005.221.183.
  • 5Robert C, Jonath an R E, Sarah P, et al. Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men[J]. Arch Intern Med, 2007, 167(13): 1373-1378.
  • 6Sniderman A D, Pedersen T, Kjekshus J. Putting low-density lipoproteins at a center stage in atherogenesis[J].Am J Cardiol, 1997, 79(1): 64-67.
  • 7李若照,陈志斌.他汀类药物治疗缺血陛脑卒中的临床研究[J].中国医学科学,2012,2(10):49-50.
  • 8Macin SM,Pema ER,Fartas EF,et al.Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome:results of a randomized, double-blind,placebo-controlled study[J].Am Heart J,2005,149 (3):451-457.
  • 9de Lemos JA,Blazing MA,Wiviott SD,et al.Early inten-sive vs a delayed conservative simvastatin strategy in pa-tients with acute coronary syndromes:phase Z of the A to Z trial[J].JAMA, 2004,292 (11):1307-1316.
  • 10Newman CB,Palmer G,Silbershatz H,et al.Safety of a-torvastatin derived from analysis of 44 completed trials in 9,416 patients[J].Am J Cardiol,2003,92(6):670-676.

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部